Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 8, 2012, Pages 1427-1432

  Najera Chuc, Alicia E ^a   Cervantes, Laura A Montiel ^a,b   Retiguin, Flor Pérez ^b   Ojeda, Jorge Vela ^a,b   Maldonado, Elba Reyes ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Acute Myeloid Leukemia; Invariant NKT cells; Lymphocyte subsets; Survival

Indexed keywords

CYTARABINE; IDARUBICIN; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TYPE; CLINICAL ARTICLE; CLINICAL TRIAL; DENDRITIC CELL; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; INVARIANT NATURAL KILLER T CELL; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; PROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATURAL KILLER T-CELLS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84864340451     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1251-x     Document Type: Article

References (19)

1. Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, Tefferi A, Elliot MA, Kaufmann SH, Mesa RA, Litzow MR (2006) Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia 20:1632-1633. doi:10.1038/sj.leu.2404032
2. Bhardwaj N (2007) Harnessing the immune system to treat cancer. J Clin Invest 117:1130-1136. doi:10.1172/JCI32136 (Pubitemid 46718397)
3. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnet AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453-474. doi:10.1182/ blood-2009-07-235358
4. Godfrey DI, Kronenberg M (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114:1379-1388. doi:10.1172/JCI200423594 (Pubitemid 40385565)
5. Hsia JY, Chen JT, Chen CY, Hsu CP, Miaw J, Huang YS, Yang CY (2005) Prognostic significance of intratumoral natural killer cells in primary resected esophageal squamous cell carcinoma. Chang Gung Med J 28:335-340 (Pubitemid 41020841)
6. Ikeda H, Chamoto K, Tsuji T, Suzuki Y, Wakita D, Takeshima T, Nishimura T (2004) The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci 95:697-703 (Pubitemid 39335087)
7. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, Kondo E, Harada M, Koseki H, Nakayama T, Tanaka Y, Taniguchi M (1998) Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated valpha14NKT cells. Proc Natl Acad Sci USA 95:5690-5693 (Pubitemid 28224157)
8. Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, Akutsu Y, Motohashi S, Lizasa T, Endo H, Fujisawa T, Shinkai H, Taniguchi M (1999) Antitumor cytotoxicity mediated by ligand-activated human Va24 NKT cells. Cancer Res 59:5102-5105 (Pubitemid 29503967)
9. Kondratiev S, Sabo E, Yakirevich E, Lavie O, Resnick MB (2004) Intratumoral CD8? T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 10:4450-4456. doi:10.1158/1078-0432.CCR- 0732-3 (Pubitemid 38878888)
10. Leite-de-Moraes MC, Herbelin A, Govarin C, Koezuka Y, Schneider E, Dy M (2000) Fas/Fas ligand interactions promote activation induced cell death of NKT lymphocytes. J Immunol 165:4367-4371
11. Metelitsa LS, Naidenko OV, Kant A, Wu H-W, Loza MJ, Perussia B, Kronemberg M, Seeger RC (2001) Human cells mediated antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 167:3114-3122 (Pubitemid 32852549)
12. Molling JW, Langius JA, Langendijk JA, Leemans CR, Bontikes HJ, van der Vliet HJJ, von Blomberg BME, Scheper RJ, van den Eertwegh AJM (2007) Low levels of circulating invariant natural killer T cells predicts poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol 7:862-868. doi: 10.1200/JCO.2006.08.5787 (Pubitemid 350002887)
13. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491-3494 (Pubitemid 28376536)
14. Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM, Markovic SN (2002) Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 16:1311-1318. doi:10.1038/sj.leu.24055003
15. Spada FM, Koezuka Y, Porcelli SA (1998) CD1d- restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 188:1529-1534. doi:10.1084/jem. 188.8.1529 (Pubitemid 28489590)
16. Tachibana T, Onodera H, Tsuruyama T, Mori A, Nagayama S, Hiai H, Imamura M (2005) Increased intratumor valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res 15:7322-7327. doi:10.1158/1078- 0432.CCR-05-0877 (Pubitemid 41507690)
17. Tahir SMA, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, Wilson SB, Balk SP, Exley MA (2001) Loss of IFN-c production by invariant NK T cells in advanced cancer. J Immunol 167: 4046-4050 (Pubitemid 32910851)
18. Yanagisawa K, Seino K-I, Ishikawa Y, Nozue M, Todoroki T, Fukao K (2002) Impaired proliferative response of Va24 NKT cells from cancer patients against a- galactosylceramide. J Immunol 168:6494-6499 (Pubitemid 34620075)
19. Zhu LY, Zhou J, Liu YZ, Pan WD (2009) Prognostic significance of natural killer cell infiltration in hepatocellular carcinoma. Ai Zhen 28:1198-1202